Effect of intratympanic application of efinaconazole 10 % solution in the guinea pig

Eur Arch Otorhinolaryngol. 2016 May;273(5):1137-42. doi: 10.1007/s00405-015-3669-7. Epub 2015 May 30.

Abstract

Efinaconazole 10 % solution is a new triazole antifungal agent developed for the topical treatment of fungal infections of the nails. The current study examined the effect of intratympanic application of efinaconazole 10 % solution in the guinea pig ear. Sixteen male Hartley guinea pigs (weight 501-620 g) were divided into 3 groups to be treated with efinaconazole 10 % solution, gentamicin (50 mg/mL), or saline solution. Topical solutions of 0.2 mL were applied through a small hole made at the tympanic bulla once daily for 7 consecutive days. Post-intervention auditory brainstem responses were obtained 7 days after the last treatment. The extent of middle ear damage and hair cell loss was investigated. The efinaconazole- and gentamicin-treated groups showed severe deterioration in auditory brainstem response threshold. Middle ear examination revealed extensive changes in the efinaconazole-treated group and medium changes in the gentamicin-treated group. Hair cells were preserved in the efinaconazole- and saline-treated groups, but severe damage was seen in the gentamicin group. In conclusion, efinaconazole 10 % solution applied intratympanically to the guinea pig middle ear caused significant middle ear inflammation and hearing impairment.

Keywords: Aspergillus; Candida; Fungus; Hearing loss; Otomycosis.

MeSH terms

  • Animals
  • Antifungal Agents / administration & dosage*
  • Ear, Middle / drug effects*
  • Evoked Potentials, Auditory, Brain Stem / drug effects*
  • Gentamicins / administration & dosage*
  • Guinea Pigs
  • Hair Cells, Auditory / drug effects
  • Hearing Loss / etiology*
  • Injection, Intratympanic
  • Male
  • Solutions
  • Triazoles / administration & dosage*

Substances

  • Antifungal Agents
  • Gentamicins
  • Solutions
  • Triazoles
  • efinaconazole